Electroporation device for improving uptake of all injected cells. Ultrasonic device for improving uptake of all injected cells. Regeneration of heart muscle area damage from previous myocardial infarction. This would be classically defined as Phase I investigational study. I studies and are moving onto Phase II or III studies focusing more on efficacy than previous studies which focused primarily on safety.
Limited release indicates the product candidate has been release to a limited market segment.
Full release indicates that a product is commercially available in the prime markets the company intends to serve. Product Candidate Technology Medical Indication Development Status Development Partners Myocardial Micro Implant System Cellular pellet placed in heart muscle To improve heart function to recover from heart attack Preclinical McGill U. Montreal, Dr. R. Chiu, Duke U. Dr. Doris Taylor, Florida Intl. U. Biomedical Engineering. Limited release Ohio State University, Dr. Pascal Goldschmidt, Dr. Glenn Cooke. To be determined.